Trials / Unknown
UnknownNCT02894255
Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Teikyo University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This prospective multicenter registry evaluates the efficacy of hybrid coronary revascularization (HCR) combining coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI) in the treatment of multivessel coronary artery disease. CABG is to be performed in the left anterior descending artery and the left circumflex artery using only arterial grafts, whereas PCI is to be conducted for the treatment of significant stenotic disease in the right coronary artery with everolimus-eluting stents (EESs). This research plans to involve patients scheduled for coronary revascularization for multivessel coronary artery disease who consent to participate in the registry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Coronary artery bypass grafting | |
| PROCEDURE | Percutaneous coronary intervention |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-09-01
- First posted
- 2016-09-09
- Last updated
- 2016-09-09
Source: ClinicalTrials.gov record NCT02894255. Inclusion in this directory is not an endorsement.